The 2018 subscription of three non-cumulative supplements (9.3, 9.4 and 9.5) to the 9th Edition of European Pharmacopoeia is now available for purchase via the EDQM Store.
The monograph for Etanercept (2895) – adopted by the Ph. Eur. Commission at its 156th Session, November 2016 – will not be published in Ph. Eur. Supplement 9.3 (publication date July 2017); as a consequence, the implementation date of the monograph will not be 1 January 2018. As agreed with the Ph. Eur. Commission at the time the monograph was adopted, publication has been postponed to ensure...
Pharmeuropa contains draft pharmacopoeial texts for which the European Pharmacopoeia Commission is seeking comment.
The EDQM will hold an international symposium on 10-11 October 2017 in Strasbourg (France) to present and discuss recent achievements, as well as future perspectives, of the Ph. Eur. in the microbiology field.
The EDQM has just published its 2016 Annual Report. The report is an opportunity to review the different activities of the past year and reflect on what the EDQM accomplished and developed.
The European Pharmacopoeia (Ph. Eur.) Commission adopted 9 new monographs at its 158th Session, which took place in Strasbourg on 20 June 2017. Other adopted texts included 49 revisions, of which 44 on monographs and 5 on general chapters.
STILL TIME TO REGISTER ! Do not miss this opportunity to expand your knowledge and familiarise yourself with the work and procedures of the European Pharmacopoeia.
Supplements 9.1 to 9.5 of the European Pharmacopoeia are now available to order on the EDQM store. These supplements, which are expected to be ready for dispatch during June, contain all the regulatory information that will come into force in the course of 2018
The European Pharmacopoeia (Ph. Eur.) Commission has launched a public consultation on its proposal to include in its texts 4 plasticisers that can be added to PVC (poly(vinyl chloride)) for manufacturing blood containers and sets for blood transfusions.
On 24 January 2017, the Permanent Representation of the Republic of Moldova to the Council of Europe handed to Mr Thorbjørn Jagland, Secretary General of the Council of Europe, the instrument of accession to the Convention on the Elaboration of a European Pharmacopoeia [European Treaty Series n° 050], as amended by the Protocol of 16 November 1989.
Pending completion of the review of the related substances test published in European Pharmacopoeia 9.0 by the group of experts, and to ensure a continuing supply of erythromycin ethylsuccinate active substance to the European markets, a revised monograph has been prepared and will be effective from 01 May 2017.
The European Pharmacopoeia (Ph. Eur.) Commission adopted 15 new monographs at its 157th Session, which took place in Strasbourg on 21-22 March.
With the publication of Supplement 9.3 of the European Pharmacopoeia, the USB version will be replaced by a downloadable version.
During a seminar coorganised with the European Medicines Agency (EMA), the EDQM clarified further the role that Ph. Eur. monographs play in the assessment of biosimilars.
With the implementation of the ICH Q3D guideline on elemental impurities, the control of elemental impurities is undergoing a shift in paradigm, moving away from pure substance-based testing towards a holistic control strategy in the finished product.